MammoScreen BD
K243685Therapixel · cleared 2025-08-22 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.6)
“MammoScreen BD is a software-only device (SaMD) using artificial intelligence to assist radiologists in the interpretation of mammograms.”
source quote (p.8)
“The system includes 'deep learning' modules for the assessment of the breast tissue composition. These modules are trained with very large databases of annotated mammograms.”
source quote (p.1)
“FDA's substantial equivalence determination also included the review and clearance of your Predetermined Change Control Plan (PCCP). Under section 515C(b)(1) of the Act, a new premarket notification is not required for a change to a device cleared under section 510(k) of the Act, if such change is consistent with an established PCCP granted pursuant to section 515C(b)(2) of the Act.”
Validation studies (3)
Retrospective clinical
n=922 patients
endpoints: Superiority in standalone performance for density assignment of MammoScreen BD compared to a pre-determined reference value (Kappareference = 0.85); Quadratically weighted Cohen's kappa between the density assessment of MammoScreen BD and the established ground truth
standards: IEC 62304:2006/A1:2016- Medical device software - Software life-cycle processes, IEC 62366-1:2015+AMD1:2020- Medical devices - Application of usability engineering to medical devices.
Retrospective clinical
n=500 patients
endpoints: Superiority in standalone performance for density assignment of MammoScreen BD compared to a pre-determined reference value (Kappareference = 0.85); Quadratically weighted Cohen's kappa between the density assessment of MammoScreen BD and the established ground truth
standards: IEC 62304:2006/A1:2016- Medical device software - Software life-cycle processes, IEC 62366-1:2015+AMD1:2020- Medical devices - Application of usability engineering to medical devices.
Retrospective clinical
n=376 patients
endpoints: Superiority in standalone performance for density assignment of MammoScreen BD compared to a pre-determined reference value (Kappareference = 0.85); Quadratically weighted Cohen's kappa between the density assessment of MammoScreen BD and the established ground truth
standards: IEC 62304:2006/A1:2016- Medical device software - Software life-cycle processes, IEC 62366-1:2015+AMD1:2020- Medical devices - Application of usability engineering to medical devices.
Reported performance (9 observations)
source quote (p.10)
“Accuracy = 85.40 with CI = [82.00, 88.40]”
source quote (p.10)
“Cohen's Kappa (quadratic) = 89.54 with CI = [86.88, 91.69]”
source quote (p.10)
“Cohen's Kappa (linear) = 83.75 with CI = [79.85, 87.00]”
source quote (p.10)
“Accuracy = 93.00 with CI = [90.80, 95.20]”
source quote (p.10)
“Cohen's Kappa (quadratic) = 86.00 with CI = [81.36, 90.25]”
source quote (p.10)
“Cohen's Kappa (linear) = 86.00 with CI = [81.36, 90.25]”
source quote (p.11)
“Kappa quadratic = 89.03 [95% CI: 87.43 – 90.56]”
source quote (p.11)
“Kappa quadratic = 89.54 [95% CI: 86.88–91.69]”
source quote (p.11)
“Kappa quadratic = 93.19 [95% CI: 90.50–94.92]”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).